Psychobiological Approaches for Anxiety Disorders - Treatment Combination Strategies
Erschienen am 29. März 2012
Software
Software-Medium
216 Seiten
978-1-119-94590-1 (ISBN)
Beschreibung
Psychobiological Approaches for Anxiety Disorders presents a comprehensive overview of the latest empirical evidence and research results on combining pharmacological agents and CBT techniques for the treatment of anxiety disorders. * The first book to focus on the issue of enhancing CBT with pharmacological agents * Features chapters from leading authors in the fields of psychiatry, pharmacology, clinical psychology, neuroscience, and emotion research * Contributes significantly to the field by summarizing the contemporary research in combination treatments in anxiety disorders * A valuable resource for clinicians in training, as well as experienced clinicians seeking to help patients with anxiety disorders
Weitere Details
Sprache
Englisch
Verlagsort
New York
USA
Zielgruppe
Für Beruf und Forschung
Maße
Höhe: 229 mm
Breite: 152 mm
Dicke: 15 mm
Gewicht
666 gr
ISBN-13
978-1-119-94590-1 (9781119945901)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Klassifikation
Weitere Ausgaben
Andere Ausgaben
E-Book
04/2012
Wiley
39,99 €
Als Download verfügbar
E-Book
03/2012
Wiley-Blackwell
39,99 €
Als Download verfügbar
Person
Stefan G. Hofmann is Professor of Psychology at Boston University and the Director of the Psychotherapy and Emotion Research Laboratory. The incoming President of the Association for Behavioral and Cognitive Therapies, he is widely published with more than 200 peer-reviewed journal articles and book chapters, and 10 books, including An Introduction to Modern CBT (2011, Wiley-Blackwell).
Inhalt
About the Contributors vii About the Editor xi Introduction 1 Stefan G. Hofmann Chapter 1 The Biology and Efficacy of Combination Strategies for Anxiety Disorders 5 Keith A. Ganasen and Dan J. Stein Chapter 2 Benzodiazepines 25 Bridget A. Hearon and Michael W. Otto Chapter 3 Tricyclic Antidepressants and Monoamine Oxidase Inhibitors 41 Franklin R. Schneier Chapter 4 Selective Serotonin Reuptake Inhibitors, Reversible Inhibitors of Monoamine Oxidase-A, and Buspirone 61 Borwin Bandelow, Markus Reitt, and Dirk Wedekind Chapter 5 D-Cycloserine 75 Adam J. Guastella and Gail A. Alvares Chapter 6 Yohimbine Hydrochloride 91 Samantha G. Farris, Michelle L. Davis, Lindsey B. DeBoer, Jasper A. J. Smits, and Mark B. Powers Chapter 7 Cortisol 109 Leila Maria Soravia and Dominique J.-F. de Quervain Chapter 8 Oxytocin 123 Markus Heinrichs, Frances S. Chen, and Gregor Domes Chapter 9 Dietary Supplements 145 Lindsey B. DeBoer, Michelle L. Davis, Mark B. Powers, and Jasper A. J. Smits Chapter 10 A Roadmap for the Research and Practice of Combination Strategies 181 Stefan G. Hofmann Index 195